Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2023-05-19 00:00:00 ET · period of report 2023-05-10 · accession 0001209191-23-030962 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-19 | 2023-05-10 | MIRM | Vig Pamela | Head of Research, Development | A - Grant | $16.92 | +684 | 32.2K | +2% | +$11.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-10 | A | A | 684 | $16.92 | 32,211 | D | — | — |